索引于
  • 学术期刊数据库
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面

抽象的

The Future of Influenza Vaccines: Developing Tools to Match Glycosylation Patterns Relevant for Protection

Vega-Sánchez José Carlos, Flores-Valdez Mario Alberto and Bravo-Madrigal Jorge

Influenza is a viral disease that is easily transmissible, and it is found around the world and can affect anyone regardless of their age group. There are 3 types of influenza viruses: A, B and C. Influenza viruses A and B are usually responsible for causing outbreaks of influenza from limited to major epidemics or even pandemics. The main preventive measure against this virus is annual vaccination, and the World Health Organization annually publishes recommendations for the production of influenza vaccines, but the protection observed so far has not been optimal. It has been proven that using egg as a substrate for vaccine production causes changes in the structure of proteins on the surface of influenza virus, and these changes could be involved in the low effectiveness of vaccines against influenza. Here we comment about platforms currently used to produce viruses for inclusion into influenza vaccines, and suggest alternatives to improve glycosylation patterns to resemble more closely those found in viruses infecting human beings, aiming to improve the effectiveness of protection conferred by these new vaccines.